We are a private company with a supportive shareholder base comprised of both corporate and institutional investors.
We have also received non-dilutive funding from Swiss and European grants, including the Commission for Technology and Innovation (CTI) and Eurostars.
Amal Therapeutics SA
c/o Fondation pour Recherches Médicales
64 av. de la Roseraie
Website by Instinctif Partners